A multi-omics study to investigate the progression of the Correa pathway in gastric mucosa in the context of cirrhosis

Table 1 Demographic characteristics of the groups

Omics type	Characteristic	Patients with cirrhosis	Control subjects	P value
Gastric microbiota genomic	Number	39	30	–
	Age, mean ± SD, years	53.40 ± 10.8	48.20 ± 14.6	0.09
	Male/female	24/15	15/15	0.46
	BMI, mean ± SD, kg/m²	24.02 ± 3.25	23.28 ± 14.62	0.36
	MELD scores	7.42 ± 4.39	–	–
Serum metabolomic	Number	22	44	–
	Age, mean ± SD, years	53.04 ± 11.08	48.32 ± 14.37	0.15
	Male/female	15/8	25/19	0.51
	BMI, mean ± SD, kg/m²	24.30 ± 4.07	22.64 ± 1.83	0.08
	MELD scores	7.70 ± 3.86	–	–
Gastric mucosa transcriptomic	Number	10	10	–
	Age, mean ± SD, years	58.10 ± 11.49	57.20 ± 14.92	0.88
	Male/female	8/2	3/7	0.07
	BMI, mean ± SD, kg/m²	24.51 ± 2.59	24.80 ± 3.07	0.82
	MELD scores	9.60 ± 4.60	–	–

Comparisons between patients with cirrhosis and controls
BMI body mass index, MELD model for end-stage liver disease, SD standard deviation

ISSN: 1757-4749